Fluticasone prop HFA 220 MCG 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26FA0SN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,663
Award facts
- Contract value 100% obligated
- $45,663.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,663.20 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for Fluticasone Propionate HFA 220 MCG inhalers (12GM units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by December 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications and medical supplies to support military healthcare programs worldwide. This delivery order for fluticasone propionate inhalers exemplifies the type of routine pharmaceutical commodity fulfillment that AmerisourceBergen provides under its broader federal contract portfolio, which encompasses specialty medications, vaccines, brand-name and generic drugs, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA0SN?
SPE2DR26FA0SN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FA0SN worth?
The government has obligated $45,663 on SPE2DR26FA0SN.
Is contract SPE2DR26FA0SN an order under another contract?
Yes. SPE2DR26FA0SN is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0SN competed?
The extent of competition for SPE2DR26FA0SN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award